Ludwig Cancer Research study develops a safer CAR-T therapy
A Ludwig Cancer Research study has devised a new type of chimeric antigen-receptor (CAR) T cell-;a family of promising immunotherapies for cancer- that can be switched on and off on demand.
Suscribirse a:
Enviar comentarios (Atom)
.jpeg)
No hay comentarios:
Publicar un comentario